版本:
中国

BRIEF-Prometic says plasminogen administration shown to reduce ALI in acute pancreatitis model

May 23 Prometic Life Sciences Inc:

* Says presents new data on PBI-4050 and plasminogen

* Prometic Life Sciences - PBI-4050 monotherapy and combination with nintedanib demonstrated promising results in treatment of idiopathic pulmonary fibrosis

* Says plasminogen administration shown to reduce acute lung injury (ALI) in an acute pancreatitis model Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐